228 related articles for article (PubMed ID: 27713177)
1. LDB1 overexpression is a negative prognostic factor in colorectal cancer.
García SA; Swiersy A; Radhakrishnan P; Branchi V; Kanth Nanduri L; Győrffy B; Betzler AM; Bork U; Kahlert C; Reißfelder C; Rahbari NN; Weitz J; Schölch S
Oncotarget; 2016 Dec; 7(51):84258-84270. PubMed ID: 27713177
[TBL] [Abstract][Full Text] [Related]
2. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
3. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
[TBL] [Abstract][Full Text] [Related]
4. Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human colorectal adenocarcinoma.
Wang YP; Guo PT; Zhu Z; Zhang H; Xu Y; Chen YZ; Liu F; Ma SP
Oncol Rep; 2017 Apr; 37(4):1961-1970. PubMed ID: 28259923
[TBL] [Abstract][Full Text] [Related]
5. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
[TBL] [Abstract][Full Text] [Related]
7. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0005075 predicts a poor prognosis and acts as an oncogene in colorectal cancer via activating Wnt/β-catenin pathway.
Jin YD; Ren YR; Gao YX; Zhang L; Ding Z
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3311-3319. PubMed ID: 31081084
[TBL] [Abstract][Full Text] [Related]
9. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells.
Huang TC; Lee PT; Wu MH; Huang CC; Ko CY; Lee YC; Lin DY; Cheng YW; Lee KH
PLoS One; 2017; 12(8):e0181034. PubMed ID: 28859077
[TBL] [Abstract][Full Text] [Related]
11. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
[TBL] [Abstract][Full Text] [Related]
12. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
13. Effects of SOX15 on the colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.
Wang S; Yang H; Chen X; Jiang Z
Future Oncol; 2018 Aug; 14(19):1921-1932. PubMed ID: 30019915
[TBL] [Abstract][Full Text] [Related]
14. VGLL4 targets a TCF4-TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer.
Jiao S; Li C; Hao Q; Miao H; Zhang L; Li L; Zhou Z
Nat Commun; 2017 Jan; 8():14058. PubMed ID: 28051067
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.
Hu L; Wang RY; Cai J; Feng D; Yang GZ; Xu QG; Zhai YX; Zhang Y; Zhou WP; Cai QP
Oncotarget; 2016 Oct; 7(41):66660-66678. PubMed ID: 27556502
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal control of lncRNA-BCAT1 and β-catenin pathway reveals lncRNA-BCAT1 long non-coding RNA acts as a tumor suppressor in colorectal cancer.
Xie F; Xiang X; Huang Q; Ran P; Yuan Y; Li Q; Qi G; Guo X; Xiao C; Zheng S
Oncotarget; 2017 Apr; 8(14):23628-23637. PubMed ID: 28416735
[TBL] [Abstract][Full Text] [Related]
17. VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6.
Dong Y; Zhang Y; Kang W; Wang G; Chen H; Higashimori A; Nakatsu G; Go M; Tong JH; Zheng S; To KF; Sung JJ; Yang X; Ng SS; Yu J
Theranostics; 2019; 9(22):6517-6531. PubMed ID: 31588233
[TBL] [Abstract][Full Text] [Related]
18. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
19. DJ-1 promotes colorectal cancer progression through activating PLAGL2/Wnt/BMP4 axis.
Zhou J; Liu H; Zhang L; Liu X; Zhang C; Wang Y; He Q; Zhang Y; Li Y; Chen Q; Zhang L; Wang K; Bu Y; Lei Y
Cell Death Dis; 2018 Aug; 9(9):865. PubMed ID: 30158634
[TBL] [Abstract][Full Text] [Related]
20. SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism.
Christensen LL; True K; Hamilton MP; Nielsen MM; Damas ND; Damgaard CK; Ongen H; Dermitzakis E; Bramsen JB; Pedersen JS; Lund AH; Vang S; Stribolt K; Madsen MR; Laurberg S; McGuire SE; Ørntoft TF; Andersen CL
Mol Oncol; 2016 Oct; 10(8):1266-82. PubMed ID: 27396952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]